These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 2899901

  • 1. [TSH-secreting pituitary adenomas].
    Beckers A, Hennen G, Reznik M, Thibaut A, Stevenaert A.
    Rev Med Liege; 1988 May 15; 43(10):396-402. PubMed ID: 2899901
    [No Abstract] [Full Text] [Related]

  • 2. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.
    Wémeau JL, Dewailly D, Leroy R, D'Herbomez M, Mazzuca M, Decoulx M, Jaquet P.
    J Clin Endocrinol Metab; 1988 Mar 15; 66(3):636-9. PubMed ID: 2895119
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun 15; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 4. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.
    Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD.
    N Engl J Med; 1987 Jul 02; 317(1):12-7. PubMed ID: 2884564
    [Abstract] [Full Text] [Related]

  • 5. Structure and function of somatostatin receptors in growth hormone control.
    Shimon I, Melmed S.
    J Endocrinol; 1997 Oct 02; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989
    [Abstract] [Full Text] [Related]

  • 6. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs.
    Rabbiosi S, Peroni E, Tronconi GM, Chiumello G, Losa M, Weber G.
    Thyroid; 2012 Oct 02; 22(10):1076-9. PubMed ID: 22947349
    [Abstract] [Full Text] [Related]

  • 7. Pituitary tumor cosecreting thyrotropin and prolactin causing hyperthyroidism--a case report.
    Song YM, Sheu WH.
    Kaohsiung J Med Sci; 2000 Apr 02; 16(4):203-9. PubMed ID: 10933752
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, Jaquet P, Epelbaum J.
    J Clin Endocrinol Metab; 1992 Aug 02; 75(2):540-6. PubMed ID: 1353505
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Response of a GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules.
    Malarkey WB, Kovacs K, O'Dorisio TM.
    Neuroendocrinology; 1989 Mar 02; 49(3):267-74. PubMed ID: 2716953
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
    Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F.
    J Clin Endocrinol Metab; 1996 Mar 02; 81(3):1164-8. PubMed ID: 8772594
    [Abstract] [Full Text] [Related]

  • 16. [Secreting pituitary adenomas].
    Linquette M, Fossati P.
    Rev Prat; 1980 Oct 11; 30(45):3017-8, 3023-6, 3031-2 passim. PubMed ID: 6255550
    [No Abstract] [Full Text] [Related]

  • 17. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
    Fischler MP, Reinhart WH.
    J Endocrinol Invest; 1999 Jan 11; 22(1):64-5. PubMed ID: 10090139
    [Abstract] [Full Text] [Related]

  • 18. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A, Sanno N, Tahara S, Osamura YR.
    Acta Neuropathol; 2004 Aug 11; 108(2):147-53. PubMed ID: 15185102
    [Abstract] [Full Text] [Related]

  • 19. [Octreotide in the treatment of thyrotropin-secreting pituitary adenomas].
    Podoba J, Hnilica P, Makaiová I, Kovácová S, Rybár M, Gecík K, Belan V, Steno J.
    Vnitr Lek; 1997 Sep 11; 43(9):607-10. PubMed ID: 9750471
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.